Pub. Date : 2020 Oct 28
PMID : 33116257
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | We identified a combination of ABT-737, a Bcl-2 family inhibitor and Purvalanol A, a CDK inhibitor, as a potential targeted therapy for AML patients with an MLL rearrangement and an FLT3-ITD. | purvalanol B | lysine methyltransferase 2A | Homo sapiens |